Latest News

 Filter by Provider

Yatra Online (NASDAQ:YTRA) reported lower revenue and an adjusted operating loss for its fiscal second quarter, as a decline in corporate group travel offset growth in its air ticketing, standalone hotel and corporate travel businesses. Revenue from operations fell 39% year over year to INR 2,136 m

TE Connectivity (NYSE:TEL) expects another year of roughly 12% organic revenue growth in fiscal 2027, with artificial intelligence, energy infrastructure and aerospace and defense contributing to the expansion, CEO Terrence Curtin said at a Baird investor event. The connectivity products company re

Gemini Space Station (NASDAQ:GEMI) reported lower third-quarter revenue as weaker retail trading and fewer large over-the-counter transactions offset stronger institutional exchange activity, even as the company reduced operating expenses for a third consecutive quarter. Total revenue fell 19% from

Cellectis (NASDAQ:CLLS) said its cash runway is expected to extend into the second half of 2028 once its planned restructuring is fully implemented, giving the gene editing company time to reach anticipated initial clinical readouts for its two lead programs. The company expects preliminary data fr

Noodles & Company (NASDAQ:NDLS) reported higher comparable sales and a narrower loss in the third quarter of 2026, as increased customer traffic and sales transferred from closed restaurants helped improve margins. Revenue fell $1.2 million from a year earlier to $120.9 million as restaurant cl

Park Dental Partners (NASDAQ:PARK) reported 6% revenue growth for the third quarter of 2026 and raised its full-year revenue outlook following the acquisition of Village Family Dental, while higher staffing costs and a cybersecurity incident weighed on profitability. Revenue rose to $64.9 million,

Cineverse (NASDAQ:CNVS) reported a 110% increase in revenue for its fiscal second quarter, as acquisitions expanded its advertising technology and media services businesses. The company also reaffirmed its full-year outlook and announced distribution rights to a new Jason Universe film. Revenue for

DiaMedica Therapeutics (NASDAQ:DMAC) expects a key interim analysis of its acute ischemic stroke trial in the first quarter of 2027, after reaching the required enrollment threshold in October, executives said on the company’s third-quarter earnings call. The company also completed enrollment in th

Subscriber growth and a seventh straight profitable quarter headline the update.

Semiconductor sales aren't slowing down, which is why it is the right time for investors to buy top names in this sector.

Health-driven shelf gains could matter as much as the production plant upgrade if demand from GLP-1 users holds, but margin recovery remains unproven.

CoreWeave helped revive AI optimism, though peer Nebius dived on its results.

TMC stock is swimming in uncertainty.

Cerebras turned core profitable for the first time and plans to triple revenue.

Collectibles surged 87% as Best Buy tests vinyl and CDs in 14 stores

One mistake could cost you benefits.

Pembina Pipeline is one dividend stock I keep coming back to. Even after a 36% run up this year, it still looks attractive with its 4.2% dividend.

A company record has investors sitting up and taking notice.

Headcount fell while revenue rose, so the operating leverage behind the next phase of growth may matter as much as the AI story.

Margins widened and debt fell sharply as consumer demand softened.

Impairment and shifting contract timing defined a mixed quarter.

Robotics revenue ramped in Q3, but the company's going concern warning and regulatory risks remain front and center.

Record growth, a potential turnaround, and a major financial challenge are pulling this EV stock in opposite directions. Here's what could determine where it goes next.

Microsoft stock fell after a widespread outage of Microsoft 365 services, including Outlook and Teams, hobbled business and government users.

Applied Digital has about $36 billion in contracted revenue, but most of the compute capacity behind it is still under construction, and the financing isn't all lined up yet.

Clinical data showing Emrosi clearing skin in 30% of patients versus 12.8% for Oracea gives the rosacea franchise its clearest edge yet.

Generating revenue from AI infrastructure is one thing, but turning that revenue into profits and attractive shareholder returns is another.

Record profit came with a cooler full-year growth outlook.

Refinancing talks and AI-driven cost cuts shape the quarter, but a debt warning lingers.

Synergies climb as fuel costs and driver shortages squeeze margins.

Record federal wins powered a first profitable quarter since the IPO.

SpaceX is hours away from its Starship Flight 15 launch, planning a double-catch for the Starship and booster. Rocket Lab preps for 100th Electron mission.

Keyera, Exchange Income, and North West show how roughly $285,000 could generate an average of $750 a month in dividends.

Alphabet stock looks like a downright bargain.

Management is planning for weak housing demand to persist into 2027, so the pricing and integration moves must carry the load in a longer downturn.

Ultrapar Participacoes (NYSE:UGP) reported third-quarter net income of BRL 2.697 billion, boosted by BRL 1.5 billion in extraordinary tax credits and stronger operating results at fuel distributor Ipiranga. Recurring earnings before interest, taxes, depreciation and amortization, or EBITDA, rose 74

Flowers Foods (NYSE:FLO) reported a 4.7% decline in third-quarter sales and revised its full-year outlook as lower bread volumes, heightened promotional activity and pressure on household budgets weighed on results. Net sales fell to approximately $1.17 billion, while volume declined 7%, with the g

BUDA (NYSEAMERICAN:BUDA), the company behind Buda Juice, reported record third-quarter 2026 revenue of $5.2 million, up 64% from a year earlier, as stronger sales at existing stores, expanded retail distribution and a new refrigerated dressings business contributed to growth. Same-store sales in th

Bk Technologies (NYSEAMERICAN:BKTI) reported higher third-quarter revenue and net income, but lowered its 2026 revenue outlook after a roof collapse disrupted production at its West Melbourne, Florida, headquarters. The public safety communications company now expects full-year revenue of $85 milli

Sigma Lithium (NASDAQ:SGML) said it produced 7,293 tons of lithium concentrate in the third quarter of 2026 after operations were stopped for about 65% of the period, but maintained a 32% net revenue margin and generated $24 million in operating cash flow. Co-Chair and CEO Ana Cabral said the compa

Yield over volume paid off, but fuel costs and currency swings still cloud the outlook.

Coinbase trades at a steeper earnings multiple despite lower profitability, while Mastercard's 45.6% net margin reflects its unmatched network scale.

The AI chip giant's stock valuation suggests shares are oversold.